<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04856319</url>
  </required_header>
  <id_info>
    <org_study_id>Implant prophylaxis</org_study_id>
    <nct_id>NCT04856319</nct_id>
  </id_info>
  <brief_title>The Effect of Pre-operative Single Dose Antibiotic Prophylaxis on the Post-operative Implant Success</brief_title>
  <official_title>The Effect of Pre-operative Single Dose Antibiotic Prophylaxis on the Post-operative Implant Success</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biruni University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biruni University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is no consensus on antibiotic prophylaxis in dental implant applications, and its&#xD;
      necessity is controversial. Current reports on antibiotic use are insufficient. Also, other&#xD;
      than antibiotic prophylaxis, data that may affect the post-operative situation such as the&#xD;
      patient's gender, age, smoking, duration of surgery, length of the operation field, flap&#xD;
      design have not been evaluated comprehensively.&#xD;
&#xD;
      This study aims to evaluate post-operative complications, implant success, and implant&#xD;
      stability in 50 individuals: preoperative single dose of 2 g amoxicillin + clavulanic acid&#xD;
      (25) and placebo (25).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>The patients and the surgeon will be masked if antibiotics or placebo were used.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Baseline implant stability / osseointegration</measure>
    <time_frame>Baseline</time_frame>
    <description>Periotest M</description>
  </primary_outcome>
  <primary_outcome>
    <measure>10th day implant stability / osseointegration</measure>
    <time_frame>10th day</time_frame>
    <description>Periotest M</description>
  </primary_outcome>
  <primary_outcome>
    <measure>1st month implant stability / osseointegration</measure>
    <time_frame>1st month</time_frame>
    <description>Periotest M</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Final implant stability / osseointegration</measure>
    <time_frame>3rd month</time_frame>
    <description>Periotest M</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Radiographic bone loss</measure>
    <time_frame>3rd month</time_frame>
    <description>The distance of the bone crest to the implant shoulder</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Early healing index (Wachtel et al)</measure>
    <time_frame>10th day</time_frame>
    <description>Complete flap closure (1), fine fibrin line (2), fibrin clot (3), partial necrosis (4), complete necrosis (5)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Early healing index (Wachtel et al)</measure>
    <time_frame>1st month</time_frame>
    <description>Complete flap closure (1), fine fibrin line (2), fibrin clot (3), partial necrosis (4), complete necrosis (5)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Operation duration</measure>
    <time_frame>Baseline</time_frame>
    <description>Duration between the first incision and the last suture</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Painkiller (0-3 days)</measure>
    <time_frame>Baseline - 3rd day</time_frame>
    <description>500 mg paracetamol, the count of the painkillers the subject used</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Painkiller (3-10 days)</measure>
    <time_frame>3rd day - 10th day</time_frame>
    <description>500 mg paracetamol, the count of the painkillers the subject used</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operation zone length</measure>
    <time_frame>Baseline</time_frame>
    <description>(mm) the crestal incision and vertical incision (if applied) length</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Tooth Loss</condition>
  <arm_group>
    <arm_group_label>Prophylaxis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2 g amoxicillin+clavulanic acid 1 hour prior to dental implant surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo 1 hour prior to dental implant surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Dental implant placement</intervention_name>
    <description>Insertion of not more than two dental implants at the same area</description>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_label>Prophylaxis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Antibiotic prophylaxis</intervention_name>
    <description>Per-os 2g amoxicillin+clavulanic acid will be administered one hour prior to the surgery</description>
    <arm_group_label>Prophylaxis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Per-os placebo (inert polysaccharide) will be administered one hour prior to the surgery</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Tooth loss&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Systemic disease&#xD;
&#xD;
          -  Lactation/pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mustafa Yılmaz, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Biruni University, assistant professor</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mustafa Yılmaz, PhD</last_name>
    <phone>+905337129952</phone>
    <email>myilmaz@biruni.edu.tr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Burcu Karaduman, PhD</last_name>
    <email>bkaraduman@biruni.edu.tr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Biruni University</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mustafa YILMAZ, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>April 12, 2021</study_first_submitted>
  <study_first_submitted_qc>April 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 23, 2021</study_first_posted>
  <last_update_submitted>May 28, 2021</last_update_submitted>
  <last_update_submitted_qc>May 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Biruni University</investigator_affiliation>
    <investigator_full_name>Mustafa YILMAZ</investigator_full_name>
    <investigator_title>Assist Prof</investigator_title>
  </responsible_party>
  <keyword>Dental Implants</keyword>
  <keyword>Antibiotic Prophylaxis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tooth Loss</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All IPD will be shared</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>Starting one year after the publication</ipd_time_frame>
    <ipd_access_criteria>All the collected data will be accessible to researchers conducting meta-analysis or examining the reliability of our study</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

